ÂÜÀòÂÒÂ×

Allen joined H&F in 1999 and is a member of the Investment Committee. He leads the Firm’s New York office and leads its investing activities in the Healthcare and Financial Services sectors.

In Healthcare, Allen is a Director of MultiPlan and Pharmaceutical Product Development (PPD) and was previously the Chairman of Sheridan Healthcare and a Director of Change Healthcare (CHNG, formerly Emdeon) and Mitchell International.

In Financial Services, Allen is a Director of Edelman Financial Engines. He was previously the Lead Director of LPL Financial (LPLA), on the Advisory Board of Grosvenor Capital Management, and a Director of investment management firms Artisan Partners (APAM), Mondrian Investment Partners and Gartmore Investment Management.

Allen was also a Director of software companies Vertafore and Activant and was involved in the Firm’s investments in media companies Axel Springer and ProSiebenSat1.

Prior to H&F, Allen was a Vice President with Pacific Equity Partners in Australia and a Manager at Bain & Company. Additionally, Allen serves on the Board of Trustees for the NYU Langone Medical Center, the Advisory Council of the Stanford Center on Longevity, the Leadership Council of Robin Hood. Previously he was a Lecturer at Stanford University.

EDUCATION

Stanford University

Harvard Business School, MBA (Baker Scholar)